The majority of people with type 1 diabetes and multiple daily insulin injections benefit from using continuous glucose monitoring: An analysis based on the GOLD randomized trial (GOLD‐5)

AIM: To identify responders to continuous glucose monitoring (CGM) in relation to reductions in HbA1c and percentage of time spent in hypoglycaemia after initiation of CGM for individuals with type 1 diabetes treated with multiple daily insulin injections. MATERIALS AND METHODS: We analysed data fro...

Descripción completa

Detalles Bibliográficos
Autores principales: Ólafsdóttir, Arndís F., Bolinder, Jan, Heise, Tim, Polonsky, William, Ekelund, Magnus, Wijkman, Magnus, Pivodic, Aldina, Ahlén, Elsa, Schwarcz, Erik, Nyström, Thomas, Hellman, Jarl, Hirsch, Irl B., Lind, Marcus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839699/
https://www.ncbi.nlm.nih.gov/pubmed/33200487
http://dx.doi.org/10.1111/dom.14257

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839699/
https://www.ncbi.nlm.nih.gov/pubmed/33200487
http://dx.doi.org/10.1111/dom.14257

Ejemplares similares